tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Recursion Pharmaceuticals call volume above normal and directionally bullish
PremiumThe FlyRecursion Pharmaceuticals call volume above normal and directionally bullish
18d ago
Nvidia hits $4T market cap, Merck acquires Verona Pharma: Morning Buzz
Premium
The Fly
Nvidia hits $4T market cap, Merck acquires Verona Pharma: Morning Buzz
24d ago
Rallybio Stock (RLYB) Rockets 25% on a Recursion Pharmaceuticals Agreement
Premium
Market News
Rallybio Stock (RLYB) Rockets 25% on a Recursion Pharmaceuticals Agreement
24d ago
Rallybio to sell interest in REV102 to Recursion Pharmaceuticals for up to $25M
PremiumThe FlyRallybio to sell interest in REV102 to Recursion Pharmaceuticals for up to $25M
25d ago
Recursion Pharmaceuticals acquires full rights to hypophosphatasia drug REV102
Premium
The Fly
Recursion Pharmaceuticals acquires full rights to hypophosphatasia drug REV102
25d ago
Recursion Pharmaceuticals assumed with an Equal Weight at Morgan Stanley
Premium
The Fly
Recursion Pharmaceuticals assumed with an Equal Weight at Morgan Stanley
30d ago
Cautious Outlook on Recursion Pharmaceuticals Amid Strategic Restructuring and Cash Management Challenges
PremiumRatingsCautious Outlook on Recursion Pharmaceuticals Amid Strategic Restructuring and Cash Management Challenges
2M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
Recursion Pharmaceuticals Announces Workforce Reduction Strategy
Premium
Company Announcements
Recursion Pharmaceuticals Announces Workforce Reduction Strategy
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100